Issue

Vol. 34 No. 5 (2022): Vol 34 Issue 5, 2022

Copyright (c) 2022 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

A Simple and Reliable RPLC Method for Simultaneous Determination of Five β-Blocker Drugs in Pharmaceuticals and Human Plasma

https://doi.org/10.14233/ajchem.2022.23611
Hassan M. Albishri
Chemistry Department, Faculty of Science, King Abdulaziz University, Solimania, 80203 Jeddah, Saudi Arabia
Basmah H Alshammari
Chemistry Department, Faculty of Science, King Abdulaziz University, Solimania, 80203 Jeddah, Saudi Arabia
Deia Abd El-Hady
Chemistry Department, Faculty of Science, University of Jeddah, Osfan Road, P.O. Box 80327, 21589 Jeddah, Saudi Arabia

Corresponding Author(s) : Hassan M. Albishri

hmalbeshri@kau.edu.sa

Asian Journal of Chemistry, Vol. 34 No. 5 (2022): Vol 34 Issue 5, 2022

Abstract

A simple and reliable simultaneous determination of β-blocker drugs (acebutolol, pindolol, atenolol, nadolol and oxprenolol) was accomplished by reversed phase liquid chromatography-ultraviolet detection (RPLC/UV). The chromatographic separation was achieved on a SB-C18 ZORBAX® column (250 mm × 4.6 mm i.d., 5 micron), using a mobile phase consisted of 0.02 mol L-1 phosphate buffer (pH = 3.5)-acetonitrile (70:30, v/v). Isocratic elution was used at a flow rate of 1.0 mL min-1. The UV detector was operated at 230 nm and the column temperature was maintained at 30 °C. Under optimal conditions, a good linearity in the range of 10-500 μg L–1 for five β-blocker drugs with the correlation of determinations (R2) higher than 0.9971 was achieved. The proposed method was successfully applied to routine analysis of several β-blockers in pharmaceutical tablets. Moreover, the results obtained from this study demonstrated that the validated method can be successfully used to routine analyze the therapeutic concentrations of several β-blockers in human plasma. The LOD and LOQ for selected β-blockers were ranged within 0.050-0.538 and 0.152-1.794 μg L-1 & 0.192-0.845 and 0.641-2.562 μg L-1, respectively, for pharmaceutical and plasma samples. Results of intra-day and inter-day precision expressed in terms of %RSD were found to be less than 2.0. Accuracy of the RPLC method was assessed by performing replicate analyses of selected β-blockers in samples against a calibration curve indicating high recoveries within 96.7-110.5%. This new method could be used for analysis of large sample series of five β-blockers in routine laboratory work.

Keywords

RPLC RPLC Acebutolol Acebutolol Pindolol Pindolol Atenolol Atenolol Nadolol Nadolol Oxprenolol Oxprenolol β-Blocker drugs β-Blocker drugs Matrices Matrices
M. Albishri, H., H Alshammari, B., & Abd El-Hady, D. (2022). A Simple and Reliable RPLC Method for Simultaneous Determination of Five β-Blocker Drugs in Pharmaceuticals and Human Plasma. Asian Journal of Chemistry, 34(5), 1119–1124. https://doi.org/10.14233/ajchem.2022.23611
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Y. Wu, L. Zeng and S. Zhao, Biomolecules, 11, 936 (2021); https://doi.org/10.3390/biom11070936
  2. R. Bruning, H. Dykes, T.W. Jones, N.B. Wayne and A.S. Newsome, Front. Pharmacol., 12, 735841 (2021); https://doi.org/10.3389/fphar.2021.735841
  3. N. Freemantle, J. Cleland, P. Young, J. Mason and J. Harrison, BMJ, 318, 1730 (1999); https://doi.org/10.1136/bmj.318.7200.1730
  4. P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, J. Handler, C. Dennison-Himmelfarb, D.T. Lackland, M.L. LeFevre, T.D. MacKenzie, O. Ogedegbe, S.C. Smith Jr., L.P. Svetkey, S.J. Taler, R.R. Townsend, J.T. Wright Jr., A.S. Narva and E. Ortiz, JAMA, 311, 507 (2014); https://doi.org/10.1001/jama.2013.284427
  5. M.S. Mahrous, A.S. Issa and N.S. Ahmed, Talanta, 39, 69 (1992); https://doi.org/10.1016/0039 9140(92)80052-F
  6. N.A. Zakhari, S.M. Hassan and Y. El-Shabrawy, Anal. Lett., 22, 3011 (1989); https://doi.org/10.1080/00032718908052413
  7. D. Pecanac, D. Radulovic, L. Zivanovic and S. Agatonovic-Kustrin, J. Pharm. Biomed. Anal., 9, 861 (1991); https://doi.org/10.1016/0731-7085(91)80014-Z
  8. I. Panderi and M. Parissi-Poulou, Int. J. Pharm., 99, 327 (1993); https://doi.org/10.1016/0378 5173(93)90376-Q
  9. R.A.S. Lapa, J.L.F.C. Lima, B.F. Reis, J.L.M. Santos and E.A.G. Zagatto, Anal. Chim. Acta, 366, 209 (1998); https://doi.org/10.1016/S0003-2670(98)00108-1
  10. S. Smarzewska and W. Ciesielski, Anal. Methods, 6, 5038 (2014); https://doi.org/10.1039/c4ay00648h
  11. A. Levent and Z. Sentürk, Anal. Lett., 43, 1448 (2010); https://doi.org/10.1080/00032710903502116
  12. I. Ali, Z.A. Al-Othman, A. Hussain, K. Saleem and H.Y. Aboul-Enein, Chromatographia, 73, 251 (2011); https://doi.org/10.1007/s10337-010-1891-4
  13. S. Morante-Zarcero and I. Sierra, Chirality, 24, 860 (2012); https://doi.org/10.1002/chir.22084
  14. Z.A. Al-Othman, A. Al-Warthan, S.D. Alam and I. Ali, Biomed. Chromatogr., 28, 1514 (2014); https://doi.org/10.1002/bmc.3259
  15. B. Yilmaz, S. Arslan and A. Asci, J. Chromatogr. Sci., 50, 914 (2012); https://doi.org/10.1093/chromsci/bms090
  16. M.M. Hefnawy, M. Al-Shehri, M.A. Abounassif and G.A.E. Mostafa, J. AOAC Int., 96, 976 (2013); https://doi.org/10.5740/jaoacint.11-191
  17. N.M. Najib, N. Idkaidek, A. Adel, B. Mohammed, S. Al-Masri, I. Admour, S.M. Alam, R. Dham and Qumaruzaman, Biopharm. Drug Dispos., 26, 1 (2005); https://doi.org/10.1002/bdd.416
  18. J. Tomková, P. Ondra, E. Kocianová and J. Václavík, Biomed. Chromatogr., 31, e3911 (2017); https://doi.org/10.1002/bmc.3911
  19. J.V. Shah, D.P. Patel, P.A. Shah, M. Sanyal and P.S. Shrivastav, Biomed. Chromatogr., 30, 208 (2016); https://doi.org/10.1002/bmc.3537
  20. M.G. Santos, I.M.C. Tavares, V.B. Boralli and E.C. Figueiredo, Analyst, 140, 2696 (2015); https://doi.org/10.1039/C4AN02066A
  21. S. Yildirim, C. Erkmen and B. Uslu, Crit. Rev. Anal. Chem., 52, 131 (2020); https://doi.org/10.1080/10408347.2020.1791043
  22. E.A. Abdel Hameed, R.A. Abdel Salam and G.M. Hadad, Spectrochim. Acta A Mol. Biomol. Spectrosc., 141, 278 (2015); https://doi.org/10.1016/j.saa.2015.01.035
  23. N.S. Mohammed, Int. J. Pharm. Sci. Res., 8, 2706 (2017).
  24. S. Ahmed, A. Alqurshi and A.-M.I. Mohamed, Talanta, 184, 296 (2018); https://doi.org/10.1016/j.talanta.2018.03.008
  25. F.A. Ibrahim, H.M. Elmansi and S.A. El Abass, Ann. Pharm. Fr., 77, 302 (2019); https://doi.org/10.1016/j.pharma.2019.02.005
  26. L. Zahálka, L. Matysová, Z. Šklubalová, S. Klovrzová and P. Solich, Chromatographia, 76, 1553 (2013); https://doi.org/10.1007/s10337-013-2457-z
  27. B. Yilmaz and S. Arslan, Sep. Sci. PLUS, 1, 4 (2018); https://doi.org/10.1002/sscp.201700023
  28. S. Ansari and M. Karimi, Med. Chem. Res., 26, 2477 (2017); https://doi.org/10.1007/s00044-017-1947 1
  29. K. Farhadi, M. Firuzi and M. Hatami, Mikrochim. Acta, 182, 323 (2015); https://doi.org/10.1007/s00604-014-1336-0
  30. H. Sereshti and S. Bakhtiari, RSC Adv., 6, 75757 (2016); https://doi.org/10.1039/C6RA11363J
  31. S.T. Ulu and Z. Aydogmus, J. Chromatogr. Sci., 50, 615 (2012); https://doi.org/10.1093/chromsci/bms056
  32. M. Silva-Gracia, A. Köppl, S. Unholzer and E. Haen, Biomed. Chromatogr., 31, e3968 (2017); https://doi.org/10.1002/bmc.3968
  33. T.A. Rodina, E.S. Mel’nikov, A.I. Dmitriev, S.A. Belkov, A.V. Sokolov, V.V. Arkhipov and A.B. Prokof’ev, Pharm. Chem. J., 51, 1111 (2018); https://doi.org/10.1007/s11094-018-1750-4
  34. M.S. Kaynak, E. Buyutuncel, H.J. Cagler and S. Sahin, Trop. J. Pharm. Res., 14, 163 (2015); https://doi.org/10.4314/tjpr.v14i1.23
  35. M.L. Wilde, K. Kümmerer and A.F. Martins, J. Braz. Chem. Soc., 23, 1732 (2012); https://doi.org/10.1590/S0103-50532012005000035
  36. A. Sarafraz-Yazdi, M.R. Abedi and Z. Es’haghi, J. Liq. Chromatogr. Relat. Technol., 36, 750 (2013); https://doi.org/10.1080/10826076.2012.673212
  37. B. Gajra, M. Patel and D.A. Patel, Int. J. Pharm. Innov., 1, 45 (2011).
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0